Skip to main content

Parenteral glutamine supplementation in critical illness: a systematic review.

Publication ,  Journal Article
Wischmeyer, PE; Dhaliwal, R; McCall, M; Ziegler, TR; Heyland, DK
Published in: Crit Care
April 18, 2014

INTRODUCTION: The potential benefit of parenteral glutamine (GLN) supplementation has been one of the most commonly studied nutritional interventions in the critical care setting. The aim of this systematic review was to incorporate recent trials of traditional parenteral GLN supplementation in critical illness with previously existing data. METHODS: All randomized controlled trials of parenterally administered GLN in critically ill patients conducted from 1997 to 2013 were identified. Studies of enteral GLN only or combined enteral/parenteral GLN were excluded. Methodological quality of studies was scored and data was abstracted by independent reviewers. RESULTS: A total of 26 studies involving 2,484 patients examining only parenteral GLN supplementation of nutrition support were identified in ICU patients. Parenteral GLN supplementation was associated with a trend towards a reduction of overall mortality (relative risk (RR) 0.88, 95% confidence interval (CI) 0.75, 1.03, P = 0.10) and a significant reduction in hospital mortality (RR 0.68, 95% CI 0.51, 0.90, P = 0.008). In addition, parenteral GLN was associated with a strong trend towards a reduction in infectious complications (RR 0.86, 95% CI 0.73, 1.02, P = 0.09) and ICU length of stay (LOS) (WMD -1.91, (95% CI -4.10, 0.28, P = 0.09) and significant reduction in hospital LOS (WMD -2.56, 95% CI -4.71, -0.42, P = 0.02). In the subset of studies examining patients receiving parenteral nutrition (PN), parenteral GLN supplementation was associated with a trend towards reduced overall mortality (RR 0.84, 95% CI 0.71, 1.01, P = 0.07). CONCLUSIONS: Parenteral GLN supplementation given in conjunction with nutrition support continues to be associated with a significant reduction in hospital mortality and hospital LOS. Parenteral GLN supplementation as a component of nutrition support should continue to be considered to improve outcomes in critically ill patients.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Crit Care

DOI

EISSN

1466-609X

Publication Date

April 18, 2014

Volume

18

Issue

2

Start / End Page

R76

Location

England

Related Subject Headings

  • Treatment Outcome
  • Parenteral Nutrition
  • Mortality
  • Length of Stay
  • Infections
  • Humans
  • Hospital Mortality
  • Glutamine
  • Emergency & Critical Care Medicine
  • Critical Care
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wischmeyer, P. E., Dhaliwal, R., McCall, M., Ziegler, T. R., & Heyland, D. K. (2014). Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care, 18(2), R76. https://doi.org/10.1186/cc13836
Wischmeyer, Paul E., Rupinder Dhaliwal, Michele McCall, Thomas R. Ziegler, and Daren K. Heyland. “Parenteral glutamine supplementation in critical illness: a systematic review.Crit Care 18, no. 2 (April 18, 2014): R76. https://doi.org/10.1186/cc13836.
Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014 Apr 18;18(2):R76.
Wischmeyer, Paul E., et al. “Parenteral glutamine supplementation in critical illness: a systematic review.Crit Care, vol. 18, no. 2, Apr. 2014, p. R76. Pubmed, doi:10.1186/cc13836.
Wischmeyer PE, Dhaliwal R, McCall M, Ziegler TR, Heyland DK. Parenteral glutamine supplementation in critical illness: a systematic review. Crit Care. 2014 Apr 18;18(2):R76.

Published In

Crit Care

DOI

EISSN

1466-609X

Publication Date

April 18, 2014

Volume

18

Issue

2

Start / End Page

R76

Location

England

Related Subject Headings

  • Treatment Outcome
  • Parenteral Nutrition
  • Mortality
  • Length of Stay
  • Infections
  • Humans
  • Hospital Mortality
  • Glutamine
  • Emergency & Critical Care Medicine
  • Critical Care